3-(1-(3-Fluorophenyl)-2-nitroethyl)-2-phenyl-1H-indole

ID: ALA4483407

PubChem CID: 155540736

Max Phase: Preclinical

Molecular Formula: C22H17FN2O2

Molecular Weight: 360.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])CC(c1cccc(F)c1)c1c(-c2ccccc2)[nH]c2ccccc12

Standard InChI:  InChI=1S/C22H17FN2O2/c23-17-10-6-9-16(13-17)19(14-25(26)27)21-18-11-4-5-12-20(18)24-22(21)15-7-2-1-3-8-15/h1-13,19,24H,14H2

Standard InChI Key:  XBRWORUVWLBYAO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   12.5490  -24.2678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5479  -25.0949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2624  -25.5076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2606  -23.8551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9759  -24.2641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9761  -25.0903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7620  -25.3455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2474  -24.6768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7615  -24.0086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0690  -24.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4811  -25.3935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3050  -25.3935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7180  -24.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3009  -23.9622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4782  -23.9656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0161  -23.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8228  -23.0524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0774  -22.2679    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4665  -22.6138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7227  -21.8287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1715  -21.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3638  -21.3879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1104  -22.1772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6634  -22.7862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8852  -22.0971    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5264  -21.6561    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3043  -22.3518    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
  9 16  1  0
 16 17  1  0
 17 18  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 16 19  1  0
 18 25  1  0
 18 26  2  0
 23 27  1  0
M  CHG  2  18   1  25  -1
M  END

Alternative Forms

  1. Parent:

    ALA4483407

    ---

Associated Targets(Human)

CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.39Molecular Weight (Monoisotopic): 360.1274AlogP: 5.38#Rotatable Bonds: 5
Polar Surface Area: 58.93Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.98CX Basic pKa: CX LogP: 5.35CX LogD: 5.34
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -0.79

References

1. Garai S, Kulkarni PM, Schaffer PC, Leo LM, Brandt AL, Zagzoog A, Black T, Lin X, Hurst DP, Janero DR, Abood ME, Zimmowitch A, Straiker A, Pertwee RG, Kelly M, Szczesniak AM, Denovan-Wright EM, Mackie K, Hohmann AG, Reggio PH, Laprairie RB, Thakur GA..  (2020)  Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators.,  63  (2): [PMID:31756109] [10.1021/acs.jmedchem.9b01142]
2. Schaffer PC,Kulkarni PM,Janero DR,Thakur GA.  (2020)  Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility.,  28  (21.0): [PMID:33065437] [10.1016/j.bmc.2020.115727]

Source